Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Determining what age to move from stocks to bonds is vital for long-term financial health. Explore guidelines to help you plan your investment strategy.
23,118 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Winter is signaling a shift in the housing market. Demand is creeping back as buyers expect holiday discounts, while ...
Europe is poised to become a leader in trusted, industrialized AI as regulators push for guardrails and firms invest ...
Credo Technology is set to report after the close, with investors watching margins and guidance as the stock prices i...
Traders pulled funds from Iran's domestic crypto venues as sanctions rhetoric intensified, signaling a liquidity risk...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
UWM introduces a temporary pricing incentive for eligible refinances and purchases, while Chase launches a short-term...
A federal judge in New York ruled that importers who paid tariffs found unconstitutional must receive refunds, settin...
European fintech Revolut is pursuing a de novo U.S. banking charter from the OCC, a move that would merge crypto serv...
Facing a pullback, Bitcoin still offers two compelling catalysts for action before June 2026. Learn the data-backed r...
A compact team aims to redefine payments by moving crypto cards onto an Ethereum layer-2. This deep dive explains how...
California prices could soon surge past seven dollars per gallon as crude costs climb and refining limits bite, with ...